Colonial Trust’s AstraZeneca AZN Stock Holding History

Colonial Trust’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$126K	Sell	661 -23	-3%	-$4.33K	0.02%	354
2026 Q1	$133K	Sell	684 -12	-2%	-$2.31K	0.02%	373
2025 Q4	$129K	Sell	696 -192	-22%	-$33.7K	0.02%	378
2025 Q3	$136K	Buy	888 +53	+6%	+$8.02K	0.02%	384
2025 Q2	$117K	Sell	835 -22	-3%	-$3.08K	0.02%	411
2025 Q1	$126K	Buy	857 +77	+10%	+$11.1K	0.02%	378
2024 Q4	$101K	Buy	780 +3	+0.4%	+$420	0.02%	443
2024 Q3	$121K	Buy	777 +37	+5%	+$5.97K	0.02%	411
2024 Q2	$115K	Buy	740 +96	+15%	+$14.4K	0.02%	380
2024 Q1	$87.9K	Sell	644 -79	-11%	-$10.5K	0.02%	426
2023 Q4	$97.2K	Sell	723 -16	-2%	-$2.08K	0.02%	399
2023 Q3	$101K	Buy	739 +28	+4%	+$3.82K	0.02%	343
2023 Q2	$101K	Sell	711 -48	-6%	-$7.06K	0.02%	345
2023 Q1	$105K	Sell	759 -33	-4%	-$4.44K	0.03%	330
2022 Q4	$107K	Buy	+792	New	+$99.3K	0.03%	300

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Colonial Trust's AZN Position: Q2 2026 in Review

Colonial Trust reduced its AstraZeneca (AZN) stake by 3.4% in Q2 2026, selling an estimated $4.33K and leaving 661 shares worth $126K. The position accounts for 0.02% of the portfolio, ranked #354.

Colonial Trust first reported a position in AZN in Q4 2022 and has held it in 15 quarters since. The position peaked at $136K in Q3 2025. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Colonial Trust held 661 shares of AstraZeneca worth $126K as of Q2 2026.
Colonial Trust sold 23 AstraZeneca shares in Q2 2026, an estimated $4.33K.
AstraZeneca made up 0.02% of Colonial Trust's portfolio in Q2 2026, its #354 holding.
Colonial Trust first reported a position in AstraZeneca in Q4 2022 and has held it in 15 quarters since.
Colonial Trust's AstraZeneca position peaked at $136K in Q3 2025.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Colonial Trust's 13F filing for Q2 2026, filed 11 Aug 2026.